PathoPredictor: A Machine Learning Framework for Predicting Pathogenic Missense Variants in the Human Genome
Open Access
- 24 March 2026
- journal article
- research article
- Published by MDPI AG in Journal of Genome Biotechnology and Genetics
- Vol. 1 (1) , 3
Abstract
Missense single nucleotide variants (SNVs) represent one of the most common forms of genetic variation and account for a substantial proportion of variants of uncertain significance in clinical databases. Accurate computational classification of these variants remains an important challenge in precision medicine and genomic research. In this study, we present PathoPredictor, an interpretable machine-learning framework designed to distinguish pathogenic from benign missense variants using curated clinical variant data and functional annotations. High-confidence variants were obtained from the November 2023 ClinVar release and annotated using dbNSFP v5.1 (GRCh37). After data filtering, imputation, and normalization, 59,302 expert-reviewed missense variants were retained for model development. Six machine-learning algorithms were evaluated under identical cross-validation conditions applied to the training set. Among the evaluated models, LightGBM demonstrated the strongest overall performance and was selected as the final PathoPredictor classifier, achieving a mean ROC–AUC of 0.93 ± 0.004, accuracy of 0.90 ± 0.006, and Matthew’s correlation coefficient of 0.80 ± 0.008 across five cross-validation folds. Model interpretability was examined using SHAP (SHapley Additive exPlanations), enabling both global feature ranking and variant-level explanation of predictions. Temporal validation using ClinVar variants submitted after November 2023 showed consistent predictive performance on previously unseen submissions within the same database ecosystem (ROC–AUC = 0.91). While the framework demonstrates strong discrimination and structured interpretability, potential limitations include training data bias and partial circularity associated with the inclusion of existing meta-predictors. Overall, PathoPredictor provides a reproducible and interpretable computational framework for integrating functional annotations in missense variant prioritization, supporting research and genomic analysis workflows.Keywords
This publication has 45 references indexed in Scilit:
- Making Sense of Missense: Benchmarking MutScore for Variant Interpretation in Inherited Cardiac DiseasesMolecular Diagnosis & Therapy, 2025
- Adapting the ACMG/AMP variant classification framework: A perspective from the ClinGen Hemoglobinopathy Variant Curation Expert PanelHuman Mutation, 2021
- Variant Interpretation: Functional Assays to the RescueThe American Journal of Human Genetics, 2017
- Clinical laboratories collaborate to resolve differences in variant interpretations submitted to ClinVarGenetics in Medicine, 2017
- Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samplesGenetics in Medicine, 2017
- REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense VariantsThe American Journal of Human Genetics, 2016
- Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research ConsortiumThe American Journal of Human Genetics, 2016
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- The Evaluation of Tools Used to Predict the Impact of Missense Variants Is Hindered by Two Types of CircularityHuman Mutation, 2015
- Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited diseaseHuman Genetics, 2013